A structural basis for the interaction of urea with lysozyme.

Por Pike, A. C., Acharya, K. R.
Publicado em 1994

Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Por Papageorgiou, A C, Shapiro, R, Acharya, K R
Publicado em 1997

A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.

Por Russo, N, Acharya, K R, Vallee, B L, Shapiro, R
Publicado em 1996

Crystal structure of bovine angiogenin at 1.5-A resolution.

Por Acharya, K R, Shapiro, R, Riordan, J F, Vallee, B L
Publicado em 1995

Crystallization and preliminary crystallographic study of an Fab fragment of a pathogenic rat monoclonal antibody against the nicotinic acetylcholine receptor.

Por Vatzaki, E. H., Acharya, K. R., Oikonomakos, N. G., Tzartos, S. J.
Publicado em 1993

Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures.

Por Papageorgiou, A. C., Plano, L. R., Collins, C. M., Acharya, K. R.
Publicado em 2000

Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease.

Por Acharya, K R, Shapiro, R, Allen, S C, Riordan, J F, Vallee, B L
Publicado em 1994

Role of glutamine-117 in the ribonucleolytic activity of human angiogenin.

Por Russo, N, Shapiro, R, Acharya, K R, Riordan, J F, Vallee, B L
Publicado em 1994

Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.

Por Oikonomakos, N. G., Zographos, S. E., Tsitsanou, K. E., Johnson, L. N., Acharya, K. R.
Publicado em 1996

Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.

Por Leonidas, D. D., Oikonomakos, N. G., Papageorgiou, A. C., Acharya, K. R., Barford, D., Johnson, L. N.
Publicado em 1992

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution.

Por Papageorgiou, A. C., Quinn, C. P., Beer, D., Brehm, R. D., Tranter, H. S., Bonventre, P. F., Acharya, K. R.
Publicado em 1996

Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.

Por Papageorgiou, A C, Collins, C M, Gutman, D M, Kline, J B, O'Brien, S M, Tranter, H S, Acharya, K R
Publicado em 1999

Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b.

Por Hajdu, J, Acharya, K R, Stuart, D I, McLaughlin, P J, Barford, D, Oikonomakos, N G, Klein, H, Johnson, L N
Publicado em 1987

N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.

Por Oikonomakos, N. G., Kontou, M., Zographos, S. E., Watson, K. A., Johnson, L. N., Bichard, C. J., Fleet, G. W., Acharya, K. R.
Publicado em 1995